GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cyclopharm Ltd (ASX:CYC) » Definitions » Pretax Margin %

Cyclopharm (ASX:CYC) Pretax Margin % : -56.62% (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Cyclopharm Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cyclopharm's Pre-Tax Income for the six months ended in Jun. 2024 was A$-7.48 Mil. Cyclopharm's Revenue for the six months ended in Jun. 2024 was A$13.21 Mil. Therefore, Cyclopharm's pretax margin for the quarter that ended in Jun. 2024 was -56.62%.

The historical rank and industry rank for Cyclopharm's Pretax Margin % or its related term are showing as below:

ASX:CYC' s Pretax Margin % Range Over the Past 10 Years
Min: -39.82   Med: -7.52   Max: 32.5
Current: -38.74


ASX:CYC's Pretax Margin % is ranked worse than
94.5% of 109 companies
in the Medical Distribution industry
Industry Median: 2.27 vs ASX:CYC: -38.74

Cyclopharm Pretax Margin % Historical Data

The historical data trend for Cyclopharm's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclopharm Pretax Margin % Chart

Cyclopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.22 -39.82 -24.55 -25.97 -15.91

Cyclopharm Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.68 -32.05 -16.33 -15.23 -56.62

Competitive Comparison of Cyclopharm's Pretax Margin %

For the Medical Distribution subindustry, Cyclopharm's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclopharm's Pretax Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cyclopharm's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Cyclopharm's Pretax Margin % falls into.



Cyclopharm Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Cyclopharm's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.19/26.339
=-15.91 %

Cyclopharm's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-7.478/13.207
=-56.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyclopharm  (ASX:CYC) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Cyclopharm Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Cyclopharm's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyclopharm Business Description

Traded in Other Exchanges
N/A
Address
Unit 4, 1 The Crescent, Kingsgrove, Sydney, NSW, AUS, 2208
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.

Cyclopharm Headlines

No Headlines